跳至主要内容
临床试验/ISRCTN03869290
ISRCTN03869290已完成未知

Effect of spironolactone on exercise capacity in older people without heart failure: a double-blind placebo-controlled trial

niversity of Dundee (UK)0 个研究点目标入组 120 人开始时间: 2008年8月21日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 65 years and over, either sex
  • 2. Self-reported problems with activities of daily living

排除标准

  • 1. A clinical diagnosis of symptomatic heart failure according to the Economic and Social Research Council (ESRC) criteria
  • 2. Asymptomatic left ventricular systolic dysfunction
  • 3. Already taking spironolactone
  • 4. On angiotensin converting enzyme inhibitor or angiotensin receptor blocker
  • 5. Systolic blood pressure less than 100 mmHg
  • 6. Serum potassium greater than 5.0 mmol/l
  • 7. Serum sodium less than 130 mmol/l
  • 8. Creatinine greater than 200 umol/l
  • 9. Estimated glomerular filtration rate (eGFR) less than 30 ml
  • 10. Addison's disease
  • 11. Previous reported intolerance of spironolactone
  • 12. Cognitive impairment precluding informed consent
  • 13. Wheelchair bound
  • 14. Unwilling to participate

研究者

发起方
niversity of Dundee (UK)

相似试验